Yingmeng Yao

ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy

G. Freeman, Jinfang Zhang, Wenyi Wei, 2023, Nature communications.

Targeting METTL3 reprograms the tumor microenvironment to improve cancer immunotherapy.

Jinfang Zhang, Wenyi Wei, Xiaolong Yan, 2023, Cell chemical biology.

USP8-governed GPX4 homeostasis orchestrates ferroptosis and cancer immunotherapy.

Wenjun Xiong, Xixin Xing, Yingmeng Yao, 2024, Proceedings of the National Academy of Sciences of the United States of America.

PD-1 regulation in immune homeostasis and immunotherapy.

Yingmeng Yao, Bin Wang, Xiangling Xiao, 2024, Cancer letters.

UFL1 ablation in T cells suppresses PD-1 UFMylation to enhance anti-tumor immunity.

B. Budiarto, Xixin Xing, Yingmeng Yao, 2024, Molecular cell.